Date of management change: January 15, 2020
Carmel, IN-based MBX-Biosciences Appointed Kent Hawryluk as President and Chief Executive Officer
MBX Biosciences is a preclinical-stage biotechnology company using validated molecular targets to create medicines for rare endocrine diseases where current therapies are inadequate.
Kent Hawryluk is President and Chief Executive Officer at MBX Biosciences. Previously, Kent held various senior HR leadership roles in the industry.
News
Short ProfileName: Kent Hawryluk
Title: President and Chief Executive Officer
Company: MBX Biosciences
Industry: Biotechnology
Current Contact InfoEmail: ****@mbxbio.com
Phone:.***
To get full contact details, please sign in or
Other IT executives who recently changed jobs as well: Latham Jennifer, Parobek Lubos, Prime Mary, Gray David, Craig Alison, Newman Cara, McKee Colin, Coombs Barbara, Stevenson Robert, Vervais Greg, Joraanstad Jake
You can find the full directory of IT executives here.
How would you like to connect with 15,000+ IT executives in charge of $ millions in IT budgets? Find details here.
